TGen and Affymetrix Partner to Use GeneChip(R) DNA Analysis Products in Major Collaborative Programs

Genotyping Technology that Leverages an Innovative Whole-Genome SNP Assay Is Available to Commercial and Academic Research Partners and Future Collaborators

12-Feb-2004

Affymetrix, Inc. and the Translational genomics Research Institute (TGen) announced that they have entered into a non-exclusive agreement under which TGen will offer genotyping services to their collaborators and NIH funded core facility programs using Affymetrix GeneChip(R) brand DNA analysis technology.

TGen currently runs gene expression core facility programs on the Affymetrix platform for The National Institutes of Mental Health and the National Institutes of Neurological Disease and Stroke. As part of this agreement, these programs have been expanded to run the Affymetrix DNA analysis technologies. Affymetrix and TGen also agreed to a framework under which they will collaborate on future projects.

"Affymetrix Mapping 10K Array is a powerful tool for linkage analysis and is available today," said Dietrich Stephan, Ph.D., Director of TGen's Neurogenomics Program. "We recently completed a complete linkage study and reproduced the disease causing gene in just five days using the 10K. Affymetrix' cutting edge technology helped realize our vision of rapidly translating genomic discovery."

"TGen's geneticists, scientific team and one of the world's fastest super computers dedicated to the study of genetics combined with the Affymetrix SNP platform will help scientists accelerate research of complex diseases and we are thrilled to be a part of that," said Affymetrix' Chief Commercial Officer Trevor J. Nicholls, Ph.D. "The flexibility and affordability of the Mapping 10K will allow TGen to provide both large research institutions and individual researchers with the most powerful genotyping technology available today."

The Mapping 10K Array meets the growing customer demand for powerful SNP genotyping solutions in basic research, clinical research and development, drug discovery, and pharmacogenomics. The Mapping 10K Array brings whole genome SNP analysis to the bench top by combining an innovative, scalable assay with a proven information platform -- one primer, one array, 10,000 SNPs. The Mapping 10K delivers the most markers and highest resolution available in a single experiment, making it easier to pinpoint genomic regions linked to disease. Applications include genetic linkage studies of inherited disease in families, cancer genetics, and population genetics.

https://www.bionity.com/en/news/35216/tgen-and-affymetrix-partner-to-use-genechip-r-dna-analysis-products-in-major-collaborative-programs.html